findmyKOL

Michael Arsenian, MD

Basic profile

Gloucester Marine Genomics Institute

ORCIDNone on fileNPI
RegionGloucester, MA · NortheastSpecialtyCardiovascular DiseaseFocusCardiology
Last active 1998findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication1998Online presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Michael Arsenian is a Cardiology physician affiliated with Gloucester Marine Genomics Institute. OpenAlex indexes 7 publications with 416 citations (h-index 6).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
7publications

Distinct works indexed by OpenAlex.

416citations

Total citations across indexed works.

6h-index

Hirsch index, productivity × impact (OpenAlex).

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

298 Washington St.
Lahey Cardiology, Gloucester
Gloucester, MA 01930

Telephone

978-282-3681

Registry record last updated 13 Jan 2016.

View the NPPES registry record

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    75.4%
    Beta blocker15.4%
    Metoprolol Succinate56%Metoprolol Tartrate14%Atenolol13%Carvedilol7%Bisoprolol Fumarate4%Sotalol3%Propranolol Hcl Er2%
    Part D<11 patients
    Statin11.1%
    Atorvastatin Calcium59%Rosuvastatin Calcium21%Pravastatin Sodium17%Simvastatin3%
    Part D<11 patients

    + 18 more classes in this area

  • Blood & clotting

    17.5%
    Factor Xa inhibitor14.5%
    Eliquis88%Xarelto12%
    Part D178 patients
    Vitamin K antagonist1.7%
    Warfarin Sodium100%
    Part D29 patients

    + 2 more classes in this area

  • Metabolism & gastrointestinal

    7.1%
    SGLT2 inhibitor4.8%
    Jardiance80%Farxiga20%
    Part D52 patients
    GLP-1 receptor agonist1.4%
    Ozempic68%Wegovy32%
    Part D<11 patients

    + 2 more classes in this area

Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”